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Background and Purpose—MRI scans of the brains of elderly people frequently show white matter lesions. Clinically,
these lesions are associated with cognitive impairment and dementia. A relation between atherosclerosis and white
matter lesions was found in some small cross-sectional studies. However, atherosclerosis is a gradual process that starts
early in life. We investigated the longitudinal association between aortic atherosclerosis assessed during midlife and late
life and cerebral white matter lesions.
Methods—We randomly sampled subjects between 60 and 90 years old from 2 population-based follow-up studies in
which subjects had their baseline examinations in 1975 to 1978 (midlife) and in 1990 to 1993 (late life). In 1995 to 1996,
subjects underwent 1.5-T MRI scanning; white matter lesions were rated in the deep subcortical and periventricular
regions separately. Aortic atherosclerosis was assessed on abdominal radiographs that were obtained from 276 subjects
in midlife and 531 subjects in late life.
Results—The presence of aortic atherosclerosis during midlife was significantly associated with the presence of
periventricular white matter lesions ’20 years later (adjusted relative risk, 2.4; 95% CI, 1.2 to 5.0); the relative risks
increased linearly with the severity of aortic atherosclerosis. No association was found between midlife aortic
atherosclerosis and subcortical white matter lesions (adjusted relative risk, 1.1; 95% CI, 0.5 to 2.3) or between late-life
aortic atherosclerosis and white matter lesions.
Conclusions—The pathogenetic process that leads to cerebral periventricular white matter lesions starts already in or
before midlife. The critical period for intervention directed at prevention of white matter lesions and its cognitive
consequences may be long before these lesions become clinically detectable. (Stroke. 2000;31:425-429.)
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Cerebral MRI scans of elderly, nondemented peoplefrequently show white matter lesions.1–4 There is evi-
dence that white matter lesions are associated with cognitive
decline and dementia.2,5–8 We previously showed an associ-
ation between atherosclerosis and white matter lesions in a
small cross-sectional population-based study among elderly
subjects.9 However, atherosclerosis is a gradual process that
starts in the first decades of life, when prevalence of white
matter lesions is very low.10–13 If atherosclerosis early in life
is a predictor for white matter lesions in later years, interven-
tion in early life might help prevent white matter lesion–
associated cognitive decline and possibly dementia. Aortic
calcification observed on an abdominal radiograph is associ-
ated with generalized atherosclerosis and has proved to be a
good predictor for the development of vascular events at
various sites, including the brain.14–17 Cerebral white matter
lesions can be located in the periventricular or the subcortical
region. It is not known whether these 2 types of lesions have
the same causes. It has been suggested that especially severe
periventricular white matter lesions are associated with im-
paired cognitive performance.7
We studied the association between the presence and
severity of aortic atherosclerosis assessed during midlife or
late life and the later presence of cerebral white matter lesions
in the Rotterdam Scan Study.
Subjects and Methods
Study Population
The Rotterdam Scan Study was designed to study determinants and
the consequences of cerebral white matter lesions in the elderly. In
1995 to 1996, 1904 subjects between 60 and 90 years old were
randomly selected in strata of age (5 years) and sex from 2 large,
ongoing, prospective follow-up cohort studies that had their baseline
examinations during the subjects’ midlife (the Zoetermeer Study) or
late life (the Rotterdam Study). The mean age of subjects during
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midlife was 53.7 years (SD, 5.5) and during late life, 68.7 years (SD,
8.0). The Zoetermeer Study had its baseline data collection in 1975
to 1978; the mean follow-up period since then was 19.6 years. The
Rotterdam Study had its baseline data collection from 1990 to 1993;
the mean follow-up period was 4.8 years. The Zoetermeer Study is
a population-based follow-up study among 10 361 subjects between
5 and 91 years old and originally focused on determinants of various
chronic diseases. The Rotterdam Study is a population-based pro-
spective follow-up cohort study among 7983 elderly subjects $55
years old that focuses on determinants of neurological, cardiovascu-
lar, locomotor, and ophthalmological disorders in the elderly. Both
studies have been described in detail elsewhere.18,19
For the Rotterdam Scan Study, subjects were invited by letter and
subsequently contacted by telephone. Upon a subject’s agreement to
participate in the study, a list of contraindications was reviewed to
assess eligibility (dementia; blindness; or presence of MRI contra-
indications, including prosthetic valves, pacemaker, cerebral aneu-
rysm clips, intraocular metal fragments, cochlear implants, and
claustrophobia). Of 1904 invited subjects, 1717 were eligible.
Complete information, including a cerebral MRI scan, was obtained
from 1077 persons (response, 63%): 563 from the Rotterdam Study
(response, 68%) and 514 from the Zoetermeer Study (response,
58%). Each participant signed an informed consent form. The study
was approved by the medical ethics committee of Erasmus
University.
Measurement of Aortic Atherosclerosis
Abdominal radiographs were taken in subjects $45 years old at the time
of baseline data collection of the Zoetermeer Study. In 305 of the 401
subjects in our study who were .45 years old at the time of baseline
data collection, a lateral abdominal radiograph had been obtained (76%,
comparable to the initial response of 82% for abdominal radiographs
back in 1975). During the follow-up study (1995 to 1996), 276 of these
radiographs could be retrieved. Abdominal radiographs were also
obtained during the baseline examination of the Rotterdam Study. An
abdominal radiograph had been obtained in 531 of our participants
(response, 94%). Aortic atherosclerosis was considered present if
calcified deposits were visible as linear densities in an area parallel and
anterior to the lumbar spine. The severity of atherosclerosis was rated as
mild when deposits were between 0 and 1 cm and as moderate to severe
when deposits were $1 cm.
Measurement of Other Baseline Covariates
All measurements were done in a similar way at baseline and
follow-up in both subpopulations of the Rotterdam Scan Study.
Height and weight were measured with the subject without shoes and
in light clothing. The body mass index was calculated as weight
divided by height squared. Blood pressure was measured 2 times on
the right arm by means of a random-zero sphygmomanometer with
the subject in the sitting position. The average of these measurements
was used. Hypertension was defined as a systolic blood pressure
$160 mm Hg and/or a diastolic blood pressure $95 mm Hg and/or
the self-reported use of blood pressure–lowering medication. Infor-
mation on smoking was obtained through a standardized question-
naire, which was checked by a physician during the interview.
Diabetes mellitus was considered present if the participant was
taking oral antidiabetics or insulin (both subpopulations) or if the
random or postload glucose level was .11.1 mmol/L (subjects
originating from the Rotterdam Study).20 Serum total cholesterol was
measured by an automated enzymatic method.21
MRI Scanning Protocol
An axial T1-, T2-, and proton density (PD)-weighted cerebral MRI
scan was made on a 1.5-T MRI scan in all participants. Subjects
recruited from the Zoetermeer Study were scanned with a 1.5-T MR
Gyroscan (Philips), and participants from the Rotterdam Study were
scanned with a 1.5-T MR Vision (Siemens). To provide compara-
bility, the following pulse sequences were applied: in the Gyroscan,
T1 (TR 700 ms, TE 14 ms), T2 (TR 2200 ms, TE 80 ms), and PD
(TR 2200 ms, TE 20 ms); and in the Vision, T1 (TR 485 ms, TE 14
ms), T2 (TR 2236 ms, TE 90 ms), and PD (TR 2236 ms, TE 20 ms).
Slice thicknesses were 6 and 5 mm, respectively, with an interslice
gap of 20.0%. The images were printed on hard copy with a
reduction factor of 2.7.
White Matter Lesion Rating Scale
White matter lesions were considered present if they were visible as
hyperintense on both PD- and T2-weighted images and not hypoin-
tense on T1-weighted images. White matter lesions were distin-
guished into those in the deep subcortical and the periventricular
regions (Figure 1). The number and size of deep subcortical white
matter lesions were rated on hard copy according to their largest
diameter in categories of small (,3 mm), medium (3 to 10 mm), or
large (.10 mm) lesions. To calculate a deep subcortical white matter
lesion volume on hard copy, white matter lesions were considered to
be spherical, with a fixed diameter per size category. Periventricular
white matter lesions were rated semiquantitatively per region:
adjacent to frontal horn (frontal capping), adjacent to lateral wall of
lateral ventricles (bands), and adjacent to occipital horn (occipital
capping) on a scale ranging from 0 (no white matter lesions), to 1
(pencil-thin periventricular lining), 2 (smooth halo or thick lining),
and 3 (large, confluent white matter lesions). The overall degree of
periventricular white matter lesions was calculated by adding up the
scores for the 3 separate categories (range, 0 to 9).
All MRI scans were examined by 2 raters from a pool of 4
experienced raters. In case of a disagreement of .1 point, a
consensus reading was held; in all other cases, the readings of both
readers were averaged. The interrater and intrarater studies showed a
good to excellent agreement. Weighted k values for grading the
periventricular white matter lesions were between 0.79 and 0.90. For
total deep subcortical white matter volume, the interreader and
intrarater intraclass correlation coefficients were 0.88 and 0.95,
respectively.
Statistical Analysis
The relation between aortic atherosclerosis and white matter lesions
was assessed by means of age- and sex-adjusted logistic regression
with the presence of severe white matter lesions as the dependent
variable. All analyses were also adjusted for the following possible
Figure 1. Example of an MRI scan with both periventricular
(solid arrow) and deep subcortical (open arrow) white matter
lesions.
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baseline confounding factors: body mass index, total serum choles-
terol, diabetes mellitus, hypertension, and smoking (never, former, or
current). The relative risk (RR), as estimated by the odds ratio, was
used to quantify the association. White matter lesions were dichot-
omized at the upper quintile of their distribution, reflecting the
presence of severe white matter lesions. Subjects without severe
white matter lesions were the reference group (lower 4 quintiles).
The association between midlife and late-life aortic atherosclerosis
and presence of white matter lesions was studied by entering aortic
atherosclerosis as a dichotomous variable (no versus mild or mod-
erate to severe) into the model. A possible dose-response relation
between the severity of aortic atherosclerosis and white matter
lesions was studied by creating dummy variables for the extent of
aortic atherosclerosis (none, mild, or moderate to severe). The
relative risks are presented with a 95% CI.
Results
Table 1 shows the baseline characteristics of the study
population. The overall response rate was 63%; it declined
from 73% among subjects between 60 and 70 years old to
48% among participants between 80 and 90 years old in 1995
to 1996. Nonparticipants from the original Zoetermeer Study
and the original Rotterdam Study were significantly older
than participants (75.6 versus 70.8 years, P,0.001, and 76.6
versus 73.7 years, P,0.001, respectively). There was no
significant difference according to sex, diastolic blood pres-
sure, or the prevalence of aortic calcification or hypertension
at baseline. Nonparticipants from the Zoetermeer Study had a
higher systolic blood pressure (135.3 versus 132.8 mm Hg,
P50.05) at baseline compared with participants, whereas this
was not significantly different for subjects from the Rotter-
dam Study.
Prevalence of aortic atherosclerosis was 21% at midlife
and 59% at late life. During midlife, 218 subjects had no
aortic atherosclerosis, whereas mild and moderate-to-severe
aortic atherosclerosis was observed in 24 and 34 subjects,
respectively. During late life, 219 subjects had no aortic
atherosclerosis, whereas mild and moderate-to-severe aortic
atherosclerosis was observed in 113 and 199 subjects, respec-
tively. At follow-up, 20% of all participants were without any
periventricular white matter lesions and 8% without subcor-
tical white matter lesions.
Table 2 shows that the presence of aortic atherosclerosis
during midlife is significantly associated with the presence of
severe periventricular white matter lesions 20 years later (RR,
2.4; 95% CI, 1.2 to 5.0) but not with deep subcortical white
matter lesions (RR, 1.1; 95% CI, 0.5 to 2.3). The risk for
severe periventricular white matter lesions 20 years later was
2.8 (95% CI, 1.0 to 7.0) for women (n5159) and 2.4 (95% CI,
0.8 to 6.7) for men (n5117). The risk for severe subcortical
white matter lesions 20 years later was 1.1 (95% CI, 0.4 to
3.4) and 0.9 (95% CI, 0.3 to 2.7) for women and men,
respectively. In contrast, the presence of aortic atherosclero-
sis during late life was not associated with either type of white
matter lesion.
Figure 2 shows a clear relation between the extent of aortic
atherosclerosis in midlife and the presence of periventricular
white matter lesions 20 years later (Ptrend50.002). There was
no such association with deep subcortical white matter
lesions (Ptrend50.68). For mild and moderate-to-severe aortic
TABLE 1. Characteristics of Participants in the Rotterdam
Scan Study During Midlife (Assessment 1975 to 1978) and Late
Life (Assessment 1990 to 1993)
Characteristic
Mid-life
Assessment
Late-life
Assessment
No. of subjects 276 531
Women, % 57.2 48.8
Mean age, y 53.8 (5.5) 68.7 (8.0)
Mean age at MRI (1995–1996) 73.4 (5.5) 73.4 (7.9)
Body mass index, kg/m2 25.3 (2.9) 26.3 (3.4)
Systolic blood pressure, mm Hg 133.8 (17.3) 136.7 (20.7)
Diastolic blood pressure, mm Hg 82.4 (10.7) 73.2 (10.8)
Serum cholesterol, mmol/L 6.2 (1.1) 6.7 (1.2)
Aortic atherosclerosis, % 21.0 58.7
Hypertension, % 30.5 38.4
Diabetes mellitus, % 0.3 4.4
Smokers, %
Current 36.0 20.2
Former 33.2 45.5
Never 30.8 34.3
Values are unadjusted means (SD) or percentages.
TABLE 2. Relative Risk (95% CI) of Severe White Matter Lesions* Associated
With Midlife and Late-Life Aortic Calcification
Aortic Calcification
in Midlife
Aortic Calcification
in Late Life
Absent Present Absent Present
No. of subjects 218 58 219 312
Periventricular white matter lesions
Model 1 1.0 (ref) 2.3 (1.2–4.6) 1.0 (ref) 0.9 (0.6–1.4)
Model 2 1.0 (ref) 2.4 (1.2–5.0) 1.0 (ref) 1.0 (0.6–1.6)
Subcortical white matter lesions
Model 1 1.0 (ref) 1.0 (0.5–2.0) 1.0 (ref) 1.1 (0.6–1.7)
Model 2 1.0 (ref) 1.1 (0.5–2.3) 1.0 (ref) 1.1 (0.6–1.8)
Model 1: adjusted for age and sex. Model 2: adjusted for age, sex, baseline presence of diabetes
mellitus, hypertension, smoking behavior, serum cholesterol, and body mass index.
*Dichotomized at the upper quintile of the severity distribution of white matter lesions.
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atherosclerosis in late life, the relative risks of having
periventricular white matter lesions were 1.0 (95% CI, 0.5 to
1.9) and 0.7 (95% CI, 0.4 to 1.3), and for deep subcortical
white matter lesions, 1.2 (95% CI, 0.6 to 2.3) and 0.8 (95%
CI, 0.4 to 1.4), respectively. Again, there were no major sex
differences in these associations.
Discussion
We found a dose-dependent relation between severity of
aortic atherosclerosis during midlife and the presence of
periventricular white matter lesions 20 years later. There was
no association between the presence of aortic atherosclerosis
in late life and white matter lesions. A strength of this study
is its large number of elderly participants from the general
population, including institutionalized persons. Another im-
portant feature is that this study is the first longitudinal study
of its kind, with a follow-up of almost 20 years.
Some limitations and methodological issues need to be
addressed. The overall response rate was 63%, and this may
have led to selection bias, especially among the oldest
participants. Still, we consider it unlikely that selection bias
has played a major role in our study, because there were only
small, nonsignificant, differences between participants and
nonparticipants. We cannot exclude the possibility that our
relative risks are somewhat underestimated, because we
performed our study in survivors of the 2 baseline studies.
Subjects who had died between baseline examination and
follow-up may have had more severe aortic atherosclerosis
than those who survived.
Another limitation is that no neuroimaging was available at
baseline of the study. This makes it difficult to provide definitive
proof of a temporal relation between aortic atherosclerosis and
white matter lesions. As for the validity of radiographic assess-
ment of aortic calcification for the diagnosis of atherosclerosis,
an autopsy study showed that radiographically detected aortic
calcification represented true intimal atherosclerosis.14 Com-
pared with CT, it was shown that calcifications seen on the
radiograph were in the vessel wall in all cases.22
The association between aortic atherosclerosis and cerebral
white matter lesions was found only for aortic plaques in
midlife and not for those found in late life. The explanation
may be that subjects who already had mild or severe aortic
atherosclerosis during midlife had progressed to more severe
atherosclerosis at the time of the MRI scan than subjects with
a similar degree of aortic atherosclerosis at a much higher
age. Apparently, it takes many years before atherosclerosis
progresses to such a severe stage that it is reflected in the
brain. Our finding of a linear relation between severity of
aortic atherosclerosis and the presence of white matter lesions
supports this interpretation. Another explanation for the weak
association between late-life aortic atherosclerosis and white
matter lesions might be that in elderly subjects, the presence
of atherosclerosis has less discriminative power, because
many other risk factors for white matter lesions coexist.
The association between aortic atherosclerosis and white
matter lesions was confined to periventricular white matter
lesions. This suggests that different pathophysiological pro-
cesses underlie periventricular and subcortical white matter
lesions, possibly related to vascularization. Because the
periventricular white matter is an arterial border zone, already
marginally perfused under physiological circumstances, it is
especially vulnerable to a decrease of cerebral blood
flow.23–25 In contrast, the subcortical white matter is not an
arterial watershed area.26 Atherosclerosis induces hyaliniza-
tion, tortuosity, and elongation of vessels in the periventric-
ular white matter.24,27–29 This may contribute to a decrease in
blood flow in the periventricular white matter, leading to
ischemia.24 This explanation is supported by studies that
found an association between periventricular white matter
lesions and atherosclerosis-related factors as hypertension,
diabetes mellitus, and the presence of silent infarcts.30
In conclusion, our study shows that aortic atherosclerosis
during midlife is a major risk factor for periventricular white
matter lesions in the brain at greater age. Our results suggest
that the presence of atherosclerosis at middle age is already
predictive for the presence of white matter lesions later in life.
Any therapeutic intervention should therefore preferably take
place at the early stages of atherosclerosis.
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